<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<?covid-19-tdm?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JMIR</journal-id>
      <journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id>
      <journal-title>Journal of Medical Internet Research</journal-title>
      <issn pub-type="epub">1438-8871</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v25i1e42623</article-id>
      <article-id pub-id-type="pmid">36603153</article-id>
      <article-id pub-id-type="doi">10.2196/42623</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Comprehensive Analysis of COVID-19 Vaccine Discourse by Vaccine Brand on Twitter in Korea: Topic and Sentiment Analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Mavragani</surname>
            <given-names>Amaryllis</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Chen</surname>
            <given-names>Anfan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Huang</surname>
            <given-names>Xiao</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" equal-contrib="yes">
          <name name-style="western">
            <surname>Park</surname>
            <given-names>Susan</given-names>
          </name>
          <degrees>MPH, PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-7082-8554</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author" corresp="yes" equal-contrib="yes">
          <name name-style="western">
            <surname>Suh</surname>
            <given-names>Young-Kyoon</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <address>
            <institution>School of Computer Science and Engineering</institution>
            <institution>Kyungpook National University</institution>
            <addr-line>80, Daehak-ro, Buk-gu</addr-line>
            <addr-line>Daegu, 41566</addr-line>
            <country>Republic of Korea</country>
            <fax>82 539574846</fax>
            <phone>82 539506372</phone>
            <email>yksuh@knu.ac.kr</email>
          </address>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-3124-2566</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Institute of Health and Environment</institution>
        <institution>Seoul National University</institution>
        <addr-line>Seoul</addr-line>
        <country>Republic of Korea</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Institute for Community Care and Health Equity</institution>
        <institution>Chung-Ang University</institution>
        <addr-line>Seoul</addr-line>
        <country>Republic of Korea</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>School of Computer Science and Engineering</institution>
        <institution>Kyungpook National University</institution>
        <addr-line>Daegu</addr-line>
        <country>Republic of Korea</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Department of Data Convergence Computing</institution>
        <institution>Kyungpook National University</institution>
        <addr-line>Daegu</addr-line>
        <country>Republic of Korea</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Young-Kyoon Suh <email>yksuh@knu.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>1</month>
        <year>2023</year>
      </pub-date>
      <volume>25</volume>
      <elocation-id>e42623</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="rev-request">
          <day>8</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </history>
      <copyright-statement>©Susan Park, Young-Kyoon Suh. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 31.01.2023.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://www.jmir.org/2023/1/e42623" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p> The unprecedented speed of COVID-19 vaccine development and approval has raised public concern about its safety. However, studies on public discourses and opinions on social media focusing on adverse events (AEs) related to COVID-19 vaccine are rare.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p> This study aimed to analyze Korean tweets about COVID-19 vaccines (Pfizer, Moderna, AstraZeneca, Janssen, and Novavax) after the vaccine rollout, explore the topics and sentiments of tweets regarding COVID-19 vaccines, and examine their changes over time. We also analyzed topics and sentiments focused on AEs related to vaccination using only tweets with terms about AEs.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p> We devised a sophisticated methodology consisting of 5 steps: keyword search on Twitter, data collection, data preprocessing, data analysis, and result visualization. We used the Twitter Representational State Transfer application programming interface for data collection. A total of 1,659,158 tweets were collected from February 1, 2021, to March 31, 2022. Finally, 165,984 data points were analyzed after excluding retweets, news, official announcements, advertisements, duplicates, and tweets with &#60;2 words. We applied a variety of preprocessing techniques that are suitable for the Korean language. We ran a suite of analyses using various Python packages, such as latent Dirichlet allocation, hierarchical latent Dirichlet allocation, and sentiment analysis.</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p> The topics related to COVID-19 vaccines have a very large spectrum, including vaccine-related AEs, emotional reactions to vaccination, vaccine development and supply, and government vaccination policies. Among them, the top major topic was AEs related to COVID-19 vaccination. The AEs ranged from the adverse reactions listed in the safety profile (eg, myalgia, fever, fatigue, injection site pain, myocarditis or pericarditis, and thrombosis) to unlisted reactions (eg, irregular menstruation, changes in appetite and sleep, leukemia, and deaths). Our results showed a notable difference in the topics for each vaccine brand. The topics pertaining to the Pfizer vaccine mainly mentioned AEs. Negative public opinion has prevailed since the early stages of vaccination. In the sentiment analysis based on vaccine brand, the topics related to the Pfizer vaccine expressed the strongest negative sentiment.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p> Considering the discrepancy between academic evidence and public opinions related to COVID-19 vaccination, the government should provide accurate information and education. Furthermore, our study suggests the need for management to correct the misinformation related to vaccine-related AEs, especially those affecting negative sentiments. This study provides valuable insights into the public discourses and opinions regarding COVID-19 vaccination.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>COVID-19</kwd>
        <kwd>vaccine</kwd>
        <kwd>vaccination</kwd>
        <kwd>Pfizer</kwd>
        <kwd>Moderna</kwd>
        <kwd>AstraZeneca</kwd>
        <kwd>Janssen</kwd>
        <kwd>Novavax</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <sec>
        <title>Background</title>
        <p>Despite progress in reducing disease mortality and morbidity in regions with high vaccination rate, challenges remain owing to uncertainties from the recently identified variants of COVID-19 [<xref ref-type="bibr" rid="ref1">1</xref>]. Moreover, because of the short duration of vaccine-induced immunity against SARS-CoV-2 and the uncertainties associated with the variants, follow-up or booster vaccinations may be required [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. In this context, it may be necessary to consider how people respond to the continuing demand for vaccination and how the government can recommend vaccination to the public.</p>
        <p>Understanding public opinion regarding COVID-19 vaccines is important for public health. Numerous studies have attempted to analyze topics and sentiments regarding COVID-19 vaccines using social media data, such as that from Twitter and Facebook [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref8">8</xref>]. However, these studies are mainly limited to data from 2020 to early 2021, which was the initial stage of vaccine development and rollout. In addition, the government’s responses to COVID-19, including vaccination policies, have changed over time. For example, the Korean government implemented a COVID-19 vaccine pass policy in December 2021 in response to the spread of Omicron variants. Changes in government policies can lead to changes in public reaction.</p>
        <p>In addition, public opinion regarding COVID-19 vaccines may be closely related to concerns about adverse events (AEs). The unprecedented speed of messenger RNA vaccine development and approval has raised concerns that clinical trials were hastened and regulatory standards were relaxed [<xref ref-type="bibr" rid="ref9">9</xref>]. Several recent topic modeling studies have reported concerns about AEs as a common major topic [<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref13">13</xref>]. Moreover, most countries have used various vaccine brands (eg, Moderna, Pfizer, AstraZeneca, and Jassen), each with different use guidelines and safety and efficacy profiles [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>]. However, there have been few in-depth studies on topics and sentiments focused on AEs, particularly over long periods after rollout.</p>
        <p>Korea reported that 70% of its population had already been fully vaccinated within 8 months of the start of the vaccination drive on February 26, 2021 [<xref ref-type="bibr" rid="ref16">16</xref>]. This result indicates that Korea reached the target vaccination rate approximately 2 months earlier than other countries that started vaccination earlier (eg, the United States, the United Kingdom, and France). As of May 31, 2022, the proportions of the Korean population with complete vaccination and an additional booster shot were 86.8% and 66.9%, respectively, making Korea one of the countries with the highest vaccination rates worldwide [<xref ref-type="bibr" rid="ref16">16</xref>].</p>
        <p>In this study, we explored the overall and brand-specific topics and sentiments related to COVID-19 vaccines in Korea after vaccine rollout. In addition, we examined their topic changes over time.</p>
      </sec>
      <sec>
        <title>Research Questions</title>
        <p>For research purpose, we raised and answered the following research questions:</p>
        <list list-type="order">
          <list-item>
            <p>What topics have been discussed on Twitter regarding COVID-19 vaccines in Korea?</p>
          </list-item>
          <list-item>
            <p>What are Twitter sentiments regarding the COVID-19 vaccines in Korea? Are they negative, positive, or neutral? Do these sentiments change over time?</p>
          </list-item>
          <list-item>
            <p>What specific topics with respect to vaccine brand types, including Pfizer, Moderna, Jassen, and AstraZeneca, are discussed on Twitter in Korea? Are there any differences among these topics?</p>
          </list-item>
          <list-item>
            <p>How about their sentiments? Do the sentiments change over time?</p>
          </list-item>
          <list-item>
            <p>What are the specific topics on Twitter in Korea with terms related to AEs of COVID-19 vaccines?</p>
          </list-item>
        </list>
      </sec>
      <sec>
        <title>Related Works</title>
        <p>We reviewed a rich body of existing literature on topics and sentiments related to COVID-19 vaccines using social media data (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref> [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref30">30</xref>]). The major data source was Twitter (21 studies), and other sources were Reddit (2 studies), Facebook (1 study), and Weibo (1 study). The period of the collected literature was from the end of 2020 to the beginning of 2021. The average duration of the data collection was 5.14 months. The shortest data collection period was 8 days [<xref ref-type="bibr" rid="ref17">17</xref>], and the longest data collection period was approximately 1 year [<xref ref-type="bibr" rid="ref11">11</xref>]. Only 3 studies collected data for &#62;10 months.</p>
      </sec>
      <sec>
        <title>Topics About the COVID-19 Vaccines</title>
        <p>Prior studies on topic modeling have shown vaccine safety and efficacy, vaccine development, national vaccination policies, and vaccine supply to be major topics in a broad framework. The most commonly derived main topic was the concern about AEs, which was the main topic reported in 6 studies [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref13">13</xref>]. Previous topic modeling studies have shown that vaccine efficacy [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref>] and hesitancy [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref19">19</xref>] are the most common topics. Vaccine development and progress were the second-most discussed topics, discussed in 5 studies [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref>]. Certain people, such as Bill Gates and Kamala Harris, were mentioned as topic words [<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>]. National vaccination policies, such as mask-wearing practices and social distancing measures, were important public discourse [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref>]. In addition, trust in the government and medical institutions [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref17">17</xref>], misinformation about vaccines [<xref ref-type="bibr" rid="ref12">12</xref>], and conspiracy theories [<xref ref-type="bibr" rid="ref18">18</xref>] have been discussed as major topics. Several topic modeling studies have identified supply [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref24">24</xref>], distribution [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref11">11</xref>], and access to vaccines [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>] as important topics. Some studies have determined vaccination priority as a major topic and discussed discourses regarding disagreements with the recommendations of the Center for Disease Control [<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>].</p>
      </sec>
      <sec>
        <title>Sentiments About the COVID-19 Vaccines</title>
        <p>A total of 20 studies presented sentiments or emotions expressed on social media regarding COVID-19 vaccines. Most of these were analyzed based on positive, neutral, and negative feelings. Nine studies showed that positive sentiments prevailed over other sentiments (neutral and negative) [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref>-<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref29">29</xref>]. Neutral emotions were dominant in 1 study [<xref ref-type="bibr" rid="ref28">28</xref>] and negative sentiments prevailed in 3 studies [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref21">21</xref>]. Several previous studies have revealed that opinions vary according to the data collection period, region, and social media platforms. In particular, 1 study showed that the sentiment scores for COVID-19 vaccines were significantly different among 3 cities in Canada [<xref ref-type="bibr" rid="ref24">24</xref>]. Two other studies revealed difference in sentiments by country and social media platform [<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>]. One study showed time-varying sentiments [<xref ref-type="bibr" rid="ref30">30</xref>]. Approximately half (50%) of Twitter users in the United States expressed neutral sentiment toward the vaccines, and 40.6% of Weibo users in China indicated a positive opinion [<xref ref-type="bibr" rid="ref20">20</xref>]. In Korea, the ratios of positive and negative sentiments of Twitter users before and after vaccination were similar. However, as the number of confirmed cases increased, the number of negative tweets also increased [<xref ref-type="bibr" rid="ref19">19</xref>]. In total, 20% (4/20) of studies analyzed emotions in a more diverse manner. Monselise et al [<xref ref-type="bibr" rid="ref7">7</xref>] analyzed 5 emotions: positive, such as joy and hopefulness, and negative, such as fear, sadness, and anger. The remaining 3 studies used the following 8 emotions: anger, fear, anticipation, trust, surprise, sadness, joy, and disgust [<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Ethics Approval</title>
        <p>This study was ethically approved by the KNU Institutional Review Board (KNU-2021-0118).</p>
      </sec>
      <sec>
        <title>Overview</title>
        <p>This section briefly describes the methods used in this study. More technical details regarding the methods are provided in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>. <xref rid="figure1" ref-type="fig">Figure 1</xref> depicts the overall methodology for our analysis, including keyword search on Twitter, data collection, data preprocessing, topic modeling, sentiment analyses, and output visualization and interpretation.</p>
        <fig id="figure1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Overall methodology for COVID-19 vaccine discourse analysis on Twitter in Korea. This illustrates how our analysis was conducted from data collection to outcome visualization. API: application programming interface; HLDA: hierarchical latent Dirichlet allocation; LDA: latent Dirichlet allocation; POS: parts of speech.</p>
          </caption>
          <graphic xlink:href="jmir_v25i1e42623_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>Data Collection and Preprocessing</title>
        <p>We built a large corpus by collecting Korean tweets mentioning COVID-19 vaccine brands (eg, Pfizer, Moderna, AstraZeneca, Janssen, and Novavax), via academic research access [<xref ref-type="bibr" rid="ref31">31</xref>] authorized by Twitter, posted from February 2021 to March 2022. We removed emoticons from the collected documents before subsequent preprocessing and then constructed an initial corpus with 1,689,158 tweets.</p>
        <p>In turn, we preprocessed the initial corpus through a series of steps from stemming through short-tweet elimination. In particular, it was found that some of the tweets in the corpus were invalid for the study. There were 2 reasons for such invalidity. First, some of the tweets were retweets. Second, some tweets were not from the general public but from government offices (eg, Gyeongsangbuk-do Provincial Office), advertisements, news media companies (eg, MBC, KBS, and SBS broadcasting company), disaster alert bots (eg, dailycoronabot), and bots collecting play scripts of a character identical to a vaccine brand’s name (eg, Jassen). <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref> presents a complete list of these invalid accounts. Thus, invalid tweets had to be removed. Tweets containing keywords with different meanings from the given keywords were also excluded. Any included web links were removed, and various synonyms were replaced with common representative words in the retained tweets. As a sanity check, if the retained tweet was an empty string or contained &#62;2 words, the tweet was discarded. Through rigorous preprocessing, 165,984 tweets were retained and used for this study. We then reformatted each preprocessed tweet into a JSON file, which was stored in MongoDB (MongoDB Inc).</p>
      </sec>
      <sec>
        <title>Analysis</title>
        <p>We conducted a suite of analyses on the refined corpus with preprocessed tweets, such as latent Dirichlet allocation (LDA)-based topic modeling, hierarchical topic modeling, and sentiment analysis. First, the LDA analysis consisted of 2 phases. In the first phase, coarse-grained LDA analysis was run to determine the general trend, regardless of the vaccine brands. In the second phase, a fine-grained LDA analysis was conducted, focusing on each vaccine brand. To conduct these LDA analyses, a morpheme analysis was run and parts of speech (POS) tagged as common noun (NNG) and proper noun (NNP), denoting general and proper Korean nouns, were extracted from the analysis, and then, the specified vaccine brand names were removed to avoid affecting the analysis. A refined corpus consisting of the identified Korean nouns was embedded as term frequency–inverse document frequency (TF-IDF) for LDA analysis. In particular, we created vaccine-specific topics using pining topic modeling. Pining topic modeling allows to control word prior for each topic. The weight of the word “Pfizer” was set to 1.0 in topic 0, and the weight was set to 0.1 in the rest of the topics by following codes. Likewise, 10 times weight was given to the word “Moderna” in Topic 1, “AstraZeneca” in Topic 2, “Janssen” in Topic 3, “NovaVax” in Topic 4. This allowed the manipulation of topics to be placed at a specific topic number. To determine the optimal number of topics, we examined various indicators such as coherence [<xref ref-type="bibr" rid="ref32">32</xref>], perplexity [<xref ref-type="bibr" rid="ref33">33</xref>], and others [<xref ref-type="bibr" rid="ref34">34</xref>-<xref ref-type="bibr" rid="ref37">37</xref>] (<xref ref-type="supplementary-material" rid="app4">Multimedia Appendix 4</xref>). We then determined that 50 is the appropriate number of topics based on these indicators. Topic labels justified by the validation process were assigned to the top 10 major topics [<xref ref-type="bibr" rid="ref38">38</xref>]. The 3 coders labeled topics based on the topic words and original Twitter texts. Then, 2 tasks for the validation test were designed, namely, label intrusion (LI) and optimal label (OL), consisting of randomly selected Twitter text and 4 possible topic labels. For the LI task, 3 possible topic labels that were most associated with the Twitter text were chosen. At the same time, 1 topic was selected from other labels related to the remaining 9 topics. In the OL task, one was the highest probable label, and the others were chosen from the 9 unrelated topic labels. The 3 coders answered 10 questionnaires per topic, 5 each for the LI and OL tasks. The validity process measured the accuracy of the coders’ labels by confirming or refuting the assigned topic labels. The measured accuracy values for total, LI, and OL were 86.33%, 90.67%, and 82%, respectively, suggesting that our topic labels were valid.</p>
        <p>Second, our hierarchical topic modeling analysis was conducted using the same TF-IDF. For this analysis, we built and trained a hierarchical LDA model 1000 times. During training, we were able to prevent the number of topics from drastically increasing by restricting new topic generation through an activated option (called freeze topics). Topic pruning was then applied to the trained model because too many topics made the interpretation challenging. To perform this pruning, the top <italic>k</italic> topics were selected at depth 1, based on the number of documents associated with each topic. For each topic, the top 3 subtopics were selected. That is, we checked if the number of documents belonging to a subtopic was greater than a threshold (ie, 330/165,984, 0.2% of the total documents in our data set), and that subtopic became a candidate for that selection. The candidates were sorted according to the order of their document counts and then the top 3 were selected. By doing so, a pruned and refined hierarchical LDA model was obtained. LDA and hierarchical topic modeling analyses were performed after embedding them as TF-IDF with Korean nouns.</p>
        <p>Third, we performed sentiment analysis on the full corpus. For this analysis, SentiStrength (version 0.0.9) [<xref ref-type="bibr" rid="ref39">39</xref>], a Python package that is one of the most popular programs, was used. The SentiStrength program uses sentences as basic units after translating the Korean text into English. This is because, by comparing the sentiment analysis results using other Korean lexicons, such as SentiStrength’s Korean lexicon and the Kunsan National University Korean Sentiment Dictionary [<xref ref-type="bibr" rid="ref40">40</xref>], the results of sentiment analysis after translation into English showed the best performance. The results of sentiment score comparison between Korean and English are presented in <xref ref-type="supplementary-material" rid="app5">Multimedia Appendix 5</xref>. To compute the sentiment score, we summed the positive and negative sentiment scores associated with the translated data (via getSentiment() in SentiStrength). Tweets with a sum of sentiments &#60;0 were classified as negative, 0 as neutral, and &#62;0 as positive.</p>
        <p>Finally, to test the mean difference in sentiment scores for each vaccine brand, ANOVA and Tukey post hoc test were performed. Time trends were examined using an autoregression model to estimate the linear regression for time series data when the errors were autocorrelated. To analyze the structural changes in the model parameters, the Chow Test for Structural Breaks was performed using this procedure [<xref ref-type="bibr" rid="ref41">41</xref>].</p>
        <p>We implemented the methodology shown in <xref rid="figure1" ref-type="fig">Figure 1</xref> in Python version 3.7.13. Various Python packages were used, such as emoji version 1.7.0, konlpy version 0.6.0, nltk version 3.7, numpy version 1.21.6, pandas version 1.3.5, pyLDAvis version 3.3.1, SentiStrength version 0.0.9, and tomotopy version 0.12.2. Statistical analyses were performed by SAS Studio (SAS Inc).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Top 10 Topic Analysis on Korean Tweets Related to COVID-19 Vaccines</title>
        <p><xref ref-type="table" rid="table1">Table 1</xref> shows the top 10 topics based on the proportion of Korean tweets about COVID-19 vaccines during the collection period. These results were obtained for research question 1. Among the top 10 topics, 6 subjects (topic numbers 3, 4, 17, 20, 32, and 40) were associated with adverse vaccination events and people’s feelings, accounting for 32.29% (53,596/165,984) of all Twitter posts.</p>
        <p>The main words in topics 3, 17, and 40 were related to systemic reactions after vaccination, such as muscle pain, headache, fatigue, mild fever, and chills. Topic 20 was mainly related to local reactions, such as specific areas on the body around the injection site (left arm, shoulder, and armpit). Topic 32 revealed experiences and various feelings (eg, pain, worry, relief, and gratitude) regarding vaccination and AEs. The keywords of topic 26 were about AEs related to COVID-19 vaccination of family and friends.</p>
        <table-wrap position="float" id="table1">
          <label>Table 1</label>
          <caption>
            <p>Top 10 topics about COVID-19 vaccines in the collected Twitter data in Korea (N=165,984).</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="340"/>
            <col width="140"/>
            <col width="520"/>
            <thead>
              <tr valign="top">
                <td>Topics</td>
                <td>Proportion, n (%)<sup>a</sup></td>
                <td>Topic words</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Topic 17: systemic reaction after vaccination</td>
                <td>15,193 (9.15)</td>
                <td>Muscle pain, headache, momsal<sup>b</sup>, symptom, Tylenol, pain, progress, mild fever, energy, and chill</td>
              </tr>
              <tr valign="top">
                <td>Topic 32: emotional reaction about vaccination</td>
                <td>12,256 (7.38)</td>
                <td>Worry, thank, booster shot, AE<sup>c</sup>, relief, suffering, cross vaccination, health, flu, and mind</td>
              </tr>
              <tr valign="top">
                <td>Topic 20: injection site pain</td>
                <td>8371 (5.04)</td>
                <td>Pain, left arm, ache, muscle pain, progress, left Geumgangmakgi<sup>d</sup>, armpit, and muscle</td>
              </tr>
              <tr valign="top">
                <td>Topic 26: concern about vaccination of intimate persons</td>
                <td>8060 (4.86)</td>
                <td>Mom, dad, friend, worry, little brother, AE, around, family, talking, and parents</td>
              </tr>
              <tr valign="top">
                <td>Topic 4: news report about vaccine</td>
                <td>6188 (3.73)</td>
                <td>Press, AE, news, Giraegi<sup>e</sup>, problem, government, Korea, United States, report, and people</td>
              </tr>
              <tr valign="top">
                <td>Topic 3; health condition after vaccination</td>
                <td>5963 (3.59)</td>
                <td>AE, head, mental, sick, all day, stunned, feeling, condition, and pain</td>
              </tr>
              <tr valign="top">
                <td>Topic 21: vaccination day</td>
                <td>5807 (3.50)</td>
                <td>Friday, work, company, vacation, Saturday, weekend, Monday, school, Thursday, and booster shot</td>
              </tr>
              <tr valign="top">
                <td>Topic 36: no-show vaccine reservation success story</td>
                <td>5626 (3.39)</td>
                <td>No-show vaccine, success, application, residual, hospital, alarm, neighborhood, Naver, ticketing, and waiting</td>
              </tr>
              <tr valign="top">
                <td>Topic 40: taking analgesics to control pain and fever</td>
                <td>5625 (3.39)</td>
                <td>Tylenol, momsal, morning, muscle pain, head, chills, pain killers, headaches, taking, and sick</td>
              </tr>
              <tr valign="top">
                <td>Topic 18: how to book a no-show vaccine</td>
                <td>4725 (2.85)</td>
                <td>Hospital, text, call, change, no-show vaccine, information, application, contact, date, and select</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table1fn1">
              <p><sup>a</sup>This represents the number of tweets assigned to the topic with the highest probability because 1 tweet has &#62;1 topic.</p>
            </fn>
            <fn id="table1fn2">
              <p><sup>b</sup>The word “momsal” is a condition caused by extreme fatigue in which one’s body aches and suffers from exhaustion or fever.</p>
            </fn>
            <fn id="table1fn3">
              <p><sup>c</sup>AE: adverse event.</p>
            </fn>
            <fn id="table1fn4">
              <p><sup>d</sup>The word “Geumgangmakgi” is a traditional Korean taekwondo technique that features a defensive posture with arms raised.</p>
            </fn>
            <fn id="table1fn5">
              <p><sup>e</sup>The word “Giraegi” is a combination of gija, the Korean word for journalists, and tsuraegi, the Korean word for trash.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Topics 18, 21, and 36 were related to vaccine access. The Korean government has recommended paid sick leaves in workplaces or official absence from schools on the day of vaccination. Thus, people preferred to get their vaccines on Thursdays or Fridays to take a break until the weekend (topic 21). No-show vaccines could be reserved on a first-come, first-served basis through a specific website (eg, Naver) or by phone call to designated clinics. Topics 36 and 18 pertained to web-based and phone reservations, respectively. Topic 4 concerned the news media and the governments of Korea and America. We also performed topic modeling by dividing data by quarterly period (data now shown). As a result, it was confirmed that the topic of vaccination changed over time, and the topic of AE prevailed in the later period compared with the initial period of vaccination.</p>
      </sec>
      <sec>
        <title>Hierarchical Topic Modeling Analysis</title>
        <p><xref rid="figure2" ref-type="fig">Figure 2</xref> shows the taxonomy of the COVID-19 vaccine discourse organized using hierarchical topic modeling. The root topic words were AE, problem, booster shot, and effect, which were consistent with the major topics in <xref ref-type="table" rid="table1">Table 1</xref>. Second-level topics were news articles on the Korean government, residual vaccine reservations and vaccination successes, AE, vaccine supply and production, and the effectiveness of vaccines against mutated viruses. Of the 16 third-level topics, 8 (50%) were related to concerns about or experiences with AEs. Other topics included vaccine production, approval, and permission. Another third-level topic was vaccine administration.</p>
        <fig id="figure2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Hierarchical topic modeling of the COVID-19 vaccine discourse on Twitter in Korea. AE: adverse event; KFDA: Korea Food &#38; Drug Administration.</p>
          </caption>
          <graphic xlink:href="jmir_v25i1e42623_fig2.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>Sentiment Analysis</title>
        <p><xref rid="figure3" ref-type="fig">Figure 3</xref> show the sentiment analysis results for Twitter posts related to COVID-19 vaccines, in response to research question 2. Overall, negative sentiments regarding COVID-19 prevailed during the study period. The average sentiment score was lowest from July 2021 to December 2021. The Chow test statistics were highly significant for break points in July 2021 and January 2022 when vaccination was intensively administered to the general population.</p>
        <p>The research question 3 is about specific topics with respect to vaccine brands.</p>
        <p>Approximately 60% (95,857/165,984) of the tweets mentioned ≥2 vaccine brands together. Thus, tweets were classified into topics by vaccine brands based on the highest topic probability calculated by pinning topic modeling to explore public opinion (<xref ref-type="table" rid="table2">Table 2</xref>). Topics related to each vaccine brand differed. The topic words for the “Pfizer” brand were related to vaccine AEs (eg, muscle pain, headache, menstruation, and pain). The topics regarding the “AstraZeneca” brand involved vaccine effectiveness against virus variants (eg, effectiveness, variant, antibody, booster shot, and prevention) and AEs (eg, AEs and thrombus). The topic words for the “Moderna” and “Janssen” brands were commonly related to vaccine access (eg, no-show vaccine, reservation, and booster shot). The topics related to the “Novavax” brand were vaccine production, supply, and the Korean government. The Korean president’s name, “Jae-in Moon,” and the keyword “president” were the top topics for Novavax. Unspecified topics without weighting the vaccine brand name were keywords related to concerns or reports on AEs, such as death, AE, and health.</p>
        <p>The average sentiment score of topics with keywords related to vaccine AEs was significantly lower than that of the other topics (ANOVA and Tukey post hoc test, <italic>P</italic>&#60;.05, data not shown). For example, the sentiment score of the pining topic of the Pfizer brand was &#62;3 times worse than that of Janssen.</p>
        <p><xref rid="figure4" ref-type="fig">Figures 4</xref> and <xref rid="figure5" ref-type="fig">5</xref> show the sentiment distribution for the various vaccine brands. These results are related to research question 4. Similar to the average sentiment score of topics by vaccine brands, the Pfizer brand showed the highest proportion of negative sentiment among the 6 vaccine brands (<xref rid="figure4" ref-type="fig">Figure 4</xref>). The average sentiment score with respect to vaccine brand did not show a significant change over time (<xref ref-type="supplementary-material" rid="app6">Multimedia Appendix 6</xref>; <xref rid="figure5" ref-type="fig">Figure 5</xref>).</p>
        <fig id="figure3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Time trend of sentiment score about COVID-19 vaccine on Twitter in Korea.</p>
          </caption>
          <graphic xlink:href="jmir_v25i1e42623_fig3.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <table-wrap position="float" id="table2">
          <label>Table 2</label>
          <caption>
            <p>Top 20 topic words and average sentiment scores for various COVID-19 vaccine brands on Twitter in Korea (N=165,984).</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="170"/>
            <col width="140"/>
            <col width="550"/>
            <col width="140"/>
            <thead>
              <tr valign="top">
                <td>Topics</td>
                <td>Proportion, n (%)<sup>a</sup></td>
                <td>Topic words</td>
                <td>Average sentiment score, mean (SE<sup>b</sup>)</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Topic 0: Pfizer</td>
                <td>46,274 (27.88)</td>
                <td>AE<sup>c</sup>, muscle pain, Tylenol, symptoms, headache, momsal<sup>d</sup>, pain, menstruation, ache, and progress</td>
                <td>−1.04 (1.31)</td>
              </tr>
              <tr valign="top">
                <td>Topic 1: Moderna</td>
                <td>53,524 (32.25)</td>
                <td>No-show vaccine, AE, booster shot, hospital, mom, worry, friend, dad, cross-vaccination, and doctor</td>
                <td>−0.33 (1.20)</td>
              </tr>
              <tr valign="top">
                <td>Topic 2: AstraZeneca</td>
                <td>22,045 (13.28)</td>
                <td>Effectiveness, AE, variant, booster shot, prevention, approval, blood clot, antibody, United States, and virus</td>
                <td>−0.48 (0.97)</td>
              </tr>
              <tr valign="top">
                <td>Topic 3: Janssen</td>
                <td>13,555 (8.17)</td>
                <td>Hospital, no-show vaccine, inoculation, United States, application, booster shot, prevention, confirmation, advance reservation, and civil defense</td>
                <td>−0.28 (0.90)</td>
              </tr>
              <tr valign="top">
                <td>Topic 4: Novavax</td>
                <td>23,506 (14.16)</td>
                <td>Government, Korea, supply, production, Moon Jae-in, United States, people, contract, Japan, and secure</td>
                <td>−0.37 (1.02)</td>
              </tr>
              <tr valign="top">
                <td>Topic 5: unspecified</td>
                <td>7080 (4.27)</td>
                <td>Death, AEs, health, report, adverse reaction, women, causality, heart, examination, and investigation</td>
                <td>−0.82 (1.17)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table2fn1">
              <p><sup>a</sup>This represents the number of tweets assigned to the topic with the highest probability because 1 tweet has &#62;1 topic.</p>
            </fn>
            <fn id="table2fn2">
              <p><sup>b</sup>All mean values between COVID-19 vaccine brands exhibit significant differences according to ANOVA and Tukey post hoc test at <italic>P</italic>&#60;.05.</p>
            </fn>
            <fn id="table2fn3">
              <p><sup>c</sup>AE: adverse event.</p>
            </fn>
            <fn id="table2fn4">
              <p><sup>d</sup>The word “Momsal” is a condition caused by extreme fatigue in which one’s body aches and suffers from exhaustion or fever.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <fig id="figure4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Proportions of positive, neutral, and negative sentiments by COVID-19 vaccine brands.</p>
          </caption>
          <graphic xlink:href="jmir_v25i1e42623_fig4.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
        <fig id="figure5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Time trend of sentiment score by COVID-19 vaccine brands.</p>
          </caption>
          <graphic xlink:href="jmir_v25i1e42623_fig5.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>AE-Centric Topic Modeling</title>
        <p>We conducted a subgroup analysis of tweets with terms related to AEs, including side effects, symptoms, AE, and AE reporting (<xref ref-type="table" rid="table3">Table 3</xref>). This analysis aimed to further understand the AE-related posts on Twitter in Korea (research question 5). The analyzed topics revealed a wide range of AE-related issues posted on Twitter in Korea. Some of the topics were presented as AEs related to the COVID-19 vaccination. Systemic and local AEs were observed, which were already analyzed in the topic modeling using all tweets. In addition, this subgroup analysis revealed heart-related AEs (palpitations and myocarditis or pericarditis), changes in appetite or sleep, and irregular menstruation. In this analysis, not only experienced AEs but also various related discourses were confirmed. For example, the discourse posted on Twitter in Korea about the death of the former president (Doo-hwan Chun), who died of leukemia, was suspicious of the AE of COVID-19 vaccination. Moreover, topics related to information delivery were also observed, such as the preventive effects of booster shots against the Omicron variant and health care workers’ (hospital, physician, and nurse) information and explanation.</p>
        <table-wrap position="float" id="table3">
          <label>Table 3</label>
          <caption>
            <p>Topics of tweets with terms related to adverse events (AE; N=15,371).</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="280"/>
            <col width="140"/>
            <col width="580"/>
            <thead>
              <tr valign="top">
                <td>Topics</td>
                <td>Proportion, n (%)<sup>a</sup></td>
                <td>Topic words</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Topic 0: systemic reaction</td>
                <td>3839 (24.98)</td>
                <td>Muscle pain, headache, Momsal<sup>b</sup>, pain, aches, mild fever, chills, fever, fatigue, and cold</td>
              </tr>
              <tr valign="top">
                <td>Topic 1: local allergic reaction</td>
                <td>931 (6.06)</td>
                <td>Armpit, hive, chest, leg, allergy, lymph node, skin, numbness, rash, and lump</td>
              </tr>
              <tr valign="top">
                <td>Topic 4: palpitation</td>
                <td>612 (3.98)</td>
                <td>Heart, exercise, palpitation, man, woman, chest, caffeine, coffee, overwork, and eyesight</td>
              </tr>
              <tr valign="top">
                <td>Topic 3: myocarditis and pericarditis</td>
                <td>1115 (7.25)</td>
                <td>Heart, chest, emergency room, myocarditis, pain, dyspnea, chest pain, pain killer, pericarditis, and allergy</td>
              </tr>
              <tr valign="top">
                <td>Topic #4: irregular menstruation</td>
                <td>1121 (7.29)</td>
                <td>Irregular bleeding, menstrual pain, vaginal bleeding, menstrual cycle, menstrual irregularity, anxiety, premenstrual syndrome, bleeding, due date, and menstrual volume</td>
              </tr>
              <tr valign="top">
                <td>Topic 5: changes in appetite and sleep</td>
                <td>1522 (9.9)</td>
                <td>Appetite, fatigue, explosion, insomnia, increase, sleep, hunger, sleepiness, digestion, and improve</td>
              </tr>
              <tr valign="top">
                <td>Topic 6: suspicion of serious side effects</td>
                <td>383 (2.49)</td>
                <td>Death, suspicion, blood cancer, Doo-hwan Chun<sup>c</sup>, government, leukemia, AE, dad, health, and cerebral hemorrhage</td>
              </tr>
              <tr valign="top">
                <td>Topic 7: case report about death or thrombosis</td>
                <td>1412 (9.19)</td>
                <td>Death, myocarditis, occurrence, case, report, blood clot, approval, thrombosis, risk, and death</td>
              </tr>
              <tr valign="top">
                <td>Topic 8: discontinuation of vaccination</td>
                <td>456 (2.97)</td>
                <td>United States, Korea, government, problem, article, disposal, health authority, Japan, suspension, and order</td>
              </tr>
              <tr valign="top">
                <td>Topic 9: effectiveness of vaccines</td>
                <td>381 (2.48)</td>
                <td>Effect, antibody, booster shot, infection, immunity, variant, confirmation, prevention, virus, and Omicron</td>
              </tr>
              <tr valign="top">
                <td>Topic 10: information on side effects</td>
                <td>760 (4.94)</td>
                <td>Hospital, AE, symptom, physician, no-show vaccine, phone, talk, information, explanation, and nurse</td>
              </tr>
              <tr valign="top">
                <td>Topic 11: concern of vaccination</td>
                <td>2839 (18.47)</td>
                <td>Worry, mom, booster shot, friend, relief, suffering, dad, cross-vaccination, brother, and family</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table3fn1">
              <p><sup>a</sup>This represents the number of tweets assigned to the topic with the highest probability because 1 tweet has &#62;1 one topic.</p>
            </fn>
            <fn id="table3fn2">
              <p><sup>b</sup>The word “Momsal” is a condition caused by extreme fatigue in which one’s body aches and suffers from exhaustion or fever.</p>
            </fn>
            <fn id="table3fn3">
              <p><sup>c</sup>The word “Doo-hwan Chun” is the name of the former president.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <p>This study showed that a wide range of topics regarding COVID-19 vaccines have been discussed on Twitter in Korea. The topics related to the COVID-19 vaccine were vaccine-related AEs; emotional reactions such as worries and appreciation for vaccination; vaccine development, supply, or application; and government vaccination policies. Among them, the most important and frequently mentioned topic was AEs related to COVID-19 vaccination. Vaccine-related AEs included systemic and local AEs, myocarditis or pericarditis, thrombus, irregular menstruation, changes in appetite and sleep, leukemia, and death. A topic modeling study in which weights were assigned to various vaccine brands found notable differences in the topics related to the various vaccine brands. The topics pertaining to the Pfizer vaccine mainly mentioned AEs, those related to Moderna and Janssen vaccines focused on vaccine access, those pertaining to AstraZeneca were related to vaccine effectiveness, and those regarding Novavax were issues related to vaccine production and supply. Although the sentiments toward COVID-19 vaccines changed over time, negative sentiments prevailed since the start of the vaccination. In terms of vaccine brands, the topics pertaining to the Pfizer vaccine expressed the strongest negative opinion.</p>
      </sec>
      <sec>
        <title>Comparison With Prior Work</title>
        <p>The diffusion of new technologies changes the methods for data collection or the analysis of people’s thoughts, feelings, and actions [<xref ref-type="bibr" rid="ref42">42</xref>]. Opinions expressed on social media provide researchers with alternative sources of qualitative and quantitative information to complement or, in some cases, provide alternatives to traditional data collection methods [<xref ref-type="bibr" rid="ref43">43</xref>]. From this perspective, the scientific method of information epidemiology has gained increasing attention for assessing public health perceptions and health status using web-based data sources [<xref ref-type="bibr" rid="ref44">44</xref>]. Recently, there has been an increasing number of studies on social media posts, and the most popular platform among them is Twitter [<xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref>].</p>
        <p>In this context, research on public discourse and opinions on COVID-19 vaccines has mainly used Twitter data [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref27">27</xref>]. Therefore, we investigated topics and sentiments related to COVID-19 vaccines using tweets. The overall topic composition was similar to that of previous studies, which included vaccine safety and efficacy, vaccine development and supply, and national vaccination policies. However, a subgroup analysis focusing on AEs allowed for a more in-depth analysis of topics related to various side effects. The results of this study showed that some topics about AEs were consistent with side effect profiles obtained from phase 3 clinical trials previously reported for messenger RNA (Pfizer and Moderna) [<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref46">46</xref>] and adenovirus vector vaccines (Jassen and AstraZeneca) [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref47">47</xref>]. Systemic reactions (eg, myalgia, headache, fatigue, pyrexia, and chills) and local reactions (eg, injection site pain) were common AEs after COVID-19 vaccination.</p>
        <p>This study identified topics for other side effects that were not reported in the preapproval clinical trials. For example, changes in menstruation, appetite, and sleep have been reported. Reports on sleep changes are rare. One study showed that sleep duration increased after vaccination based on wearable device data [<xref ref-type="bibr" rid="ref48">48</xref>]. Changes in the menstrual cycle and unexpected vaginal bleeding are not listed in the safety profile, but there have been reports of people experiencing these symptoms immediately after vaccination [<xref ref-type="bibr" rid="ref49">49</xref>]. Although the evidence is limited, recent studies have determined the association between menstrual changes and COVID-19 vaccination [<xref ref-type="bibr" rid="ref50">50</xref>]. Public concern is increasing because irregular menstruation can affect fertility [<xref ref-type="bibr" rid="ref51">51</xref>]. This study revealed the experiences of menstrual cycle changes in Korean women. Further studies are required to determine the causal relationship between menstrual cycle changes and COVID-19 vaccination.</p>
        <p>In addition, Korean tweets indicated public suspicion of vaccination and the occurrence of leukemia. To date, there has been no evidence of an association between leukemia and COVID-19 vaccination. However, many Korean tweets mentioned that the occurrence of leukemia in the former President Doo-hwan Chun could be related to COVID-19 vaccination. Vaccine-related misinformation on social media platforms may exacerbate vaccine hesitancy [<xref ref-type="bibr" rid="ref52">52</xref>]. To prevent the spread of misinformation, the government needs to understand the public opinions expressed on social media and respond appropriately.</p>
        <p>Several other studies that analyzed sentiments toward COVID-19 vaccines reported positive public opinion [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref>-<xref ref-type="bibr" rid="ref27">27</xref>]. However, this study showed that public opinion was consistently negative toward COVID-19 vaccination over 1 year since the start of vaccination. Negative sentiments were most pronounced when vaccination was initiated in people in their 20s and 50s. Moreover, negative public opinion was maintained on Twitter in Korea until &#62;80% (approximately 41 million/51 million) of the population was vaccinated. Our results agree with the limited number of previous Korean studies conducted during the early stages of vaccination. In a survey conducted at the start of vaccination, more than half of the population hesitated to receive the vaccine [<xref ref-type="bibr" rid="ref53">53</xref>]. A study analyzing Twitter data during the first month of vaccination showed that public sentiment toward the vaccine was negative in Korea [<xref ref-type="bibr" rid="ref19">19</xref>].</p>
        <p>Two possible explanations for these results are the compulsory vaccination policy and the experiences and concerns regarding AEs after vaccination. After the Omicron variant epidemic, the Korean government permitted only fully vaccinated people to use public places, such as restaurants, cafes, and movie theaters. Similarly, many nations have adopted mandatory vaccinations, including Australia, Brazil, Canada, France, Indonesia, Italy, and the United Kingdom [<xref ref-type="bibr" rid="ref54">54</xref>]. In France, approximately half of the respondents opposed such a policy [<xref ref-type="bibr" rid="ref55">55</xref>]. Thus, a compulsory vaccination policy might worsen public opinion in Korea. Another reason is that concerns or experiences of adverse effects after vaccination may exacerbate negative sentiments. In addition, suspicions about death and serious AEs (eg, leukemia) might have affected these sentiments. The results of this study showed that topics with many keywords related to AEs had lower sentiment scores than others. Considering the continuous evolution of variant viruses and the short duration of immunity of vaccines, additional vaccination may be necessary [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. The Korean government should manage misinformation and provide accurate information related to AEs to decrease the negative public opinion.</p>
        <p>The sentiment analysis by vaccine brands suggests that the Pfizer brand had the strongest negative score among the 5 vaccine brands, which was inconsistent with the previous results of phase 3 clinical trials and postmarketing surveillance. Initial trials of Pfizer revealed no significant differences in side effects compared with other vaccine brands. Rather, it was more effective in preventing symptomatic COVID-19 than the AstraZeneca and Jassen vaccines [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref>]. The postmarketing surveillance showed that severe AEs, such as deaths, for Pfizer and Moderna were similar [<xref ref-type="bibr" rid="ref56">56</xref>]. This discrepancy between academic evidence and public opinion may be because Pfizer vaccine was first inoculated in older people and patients with underlying disease in Korea. Therefore, the Pfizer vaccine may have more reported side effects in the early period of vaccination, which could affect the negative sentiment. Furthermore, cross-vaccination mainly used the Pfizer vaccine as the second dose. Although there have been controversial results in terms of the association between cross-vaccination and the severity of side effects [<xref ref-type="bibr" rid="ref57">57</xref>], people are more likely to be concerned about cross-vaccination compared with the same vaccine inoculation. Thus, the circumstances regarding Pfizer vaccination in Korea may affect negative sentiments.</p>
        <p>To the best of our knowledge, few studies have comprehensively analyzed Korean tweets more than a year after the start of vaccination to determine people’s opinions and perceptions of COVID-19 vaccines. Our topic analysis provides a hierarchical view of the topics related to COVID-19 vaccines that are mainly discussed on a web-based social media platform. Moreover, we tracked the trend of sentiments toward COVID-19 vaccines over time. We also conducted quarter-based topic analyses to reflect the rapidly changing COVID-19 circumstances. Finally, we carefully refined the Korean tweets using various preprocessing methods to obtain high-quality results.</p>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>First, caution is needed in interpretation because the relationship between vaccination and response was not analyzed and the topics about AEs did not represent a causal relationship. Second, this study only used the Twitter data. Thus, other social media platforms may contain different opinions because their preferences may vary depending on user characteristics. Third, because most social media users were young adults, our findings may not reflect the views of the entire population. Fourth, our sentiment analysis relied on English translation because of the absence of an adequate tool suitable for the Korean language. Thus, sentiment scores may have been significantly influenced by the success of translation. Furthermore, we dealt only with nouns for topic modeling. Other parts of speech, such as adjectives, adverbs, and verbs, will be considered in future studies. Finally, our sentiment analysis was performed after English translation because of the dependency on the SentiStrength program. Although we double-checked that the translation did not affect the quality of the sentiment analysis results, there could be ambiguity and uncertainty in the translation process, as indicated in the study by Huang et al [<xref ref-type="bibr" rid="ref58">58</xref>].</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>Our results showed persistent public discourses about AEs after vaccination and predominantly negative sentiments on Twitter in Korea. These results suggest that accurate information regarding vaccine-related AEs should be communicated to the general public. In addition, a continuous analysis of public opinion, not a one-time event, is required, and crisis communication should be continuously conducted according to public opinion changes. In particular, the Pfizer vaccine had the most negative sentiment from the early period of vaccination among the five vaccine brands, showing that public opinion is not based on academic evidence. Misinformation on web-based platforms should be controlled properly from a public health perspective. Furthermore, this study on public discourse and opinions after large-scale vaccination over a short period can be a valuable resource for responding to outbreaks of other emerging infectious diseases.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Summary of topics and sentiments from previous studies on COVID-19 vaccines using social media data.</p>
        <media xlink:href="jmir_v25i1e42623_app1.docx" xlink:title="DOCX File , 25 KB"/>
      </supplementary-material>
      <supplementary-material id="app2">
        <label>Multimedia Appendix 2</label>
        <p>Detailed algorithms and descriptions of each phase of COVID-19 vaccine discourse analysis.</p>
        <media xlink:href="jmir_v25i1e42623_app2.docx" xlink:title="DOCX File , 33 KB"/>
      </supplementary-material>
      <supplementary-material id="app3">
        <label>Multimedia Appendix 3</label>
        <p>A list of excluded Twitter accounts.</p>
        <media xlink:href="jmir_v25i1e42623_app3.xlsx" xlink:title="XLSX File  (Microsoft Excel File), 7 KB"/>
      </supplementary-material>
      <supplementary-material id="app4">
        <label>Multimedia Appendix 4</label>
        <p>The methods for selecting the optimal number of topics in latent Dirichlet allocation.</p>
        <media xlink:href="jmir_v25i1e42623_app4.docx" xlink:title="DOCX File , 251 KB"/>
      </supplementary-material>
      <supplementary-material id="app5">
        <label>Multimedia Appendix 5</label>
        <p>Comparison of sentiment analysis using original Korean texts and translated English texts.</p>
        <media xlink:href="jmir_v25i1e42623_app5.docx" xlink:title="DOCX File , 18 KB"/>
      </supplementary-material>
      <supplementary-material id="app6">
        <label>Multimedia Appendix 6</label>
        <p>The results of autoregression between sentiment score and time by Covid-19 vaccine brands.</p>
        <media xlink:href="jmir_v25i1e42623_app6.docx" xlink:title="DOCX File , 15 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">AE</term>
          <def>
            <p>adverse event</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">LDA</term>
          <def>
            <p>latent Dirichlet allocation</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">LI</term>
          <def>
            <p>label intrusion</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">OL</term>
          <def>
            <p>optimal label</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">TF-IDF</term>
          <def>
            <p>term frequency–inverse document frequency</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grants NRF-2018R1A6A1A03025109 and 2021R1I1A1A01059268).</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rudan</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Adeloye</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Sheikh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>COVID-19: vaccines, efficacy and effects on variants</article-title>
          <source>Curr Opin Pulm Med</source>
          <year>2022</year>
          <month>05</month>
          <day>01</day>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>180</fpage>
          <lpage>91</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35200162/"/>
          </comment>
          <pub-id pub-id-type="doi">10.1097/MCP.0000000000000868</pub-id>
          <pub-id pub-id-type="medline">35200162</pub-id>
          <pub-id pub-id-type="pii">00063198-900000000-98892</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Goel</surname>
              <given-names>RR</given-names>
            </name>
            <name name-style="western">
              <surname>Painter</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Apostolidis</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Mathew</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Meng</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Rosenfeld</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Lundgreen</surname>
              <given-names>KA</given-names>
            </name>
            <name name-style="western">
              <surname>Reynaldi</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Khoury</surname>
              <given-names>DS</given-names>
            </name>
            <name name-style="western">
              <surname>Pattekar</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Gouma</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Kuri-Cervantes</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Hicks</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Dysinger</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Hicks</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Sharma</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Herring</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Korte</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Baxter</surname>
              <given-names>AE</given-names>
            </name>
            <name name-style="western">
              <surname>Oldridge</surname>
              <given-names>DA</given-names>
            </name>
            <name name-style="western">
              <surname>Giles</surname>
              <given-names>JR</given-names>
            </name>
            <name name-style="western">
              <surname>Weirick</surname>
              <given-names>ME</given-names>
            </name>
            <name name-style="western">
              <surname>McAllister</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Awofolaju</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Tanenbaum</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Drapeau</surname>
              <given-names>EM</given-names>
            </name>
            <name name-style="western">
              <surname>Dougherty</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Long</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>D'Andrea</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Hamilton</surname>
              <given-names>JT</given-names>
            </name>
            <name name-style="western">
              <surname>McLaughlin</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Williams</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Adamski</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Kuthuru</surname>
              <given-names>O</given-names>
            </name>
            <collab>UPenn COVID Processing Unit</collab>
            <name name-style="western">
              <surname>Frank</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Betts</surname>
              <given-names>MR</given-names>
            </name>
            <name name-style="western">
              <surname>Vella</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Grifoni</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Weiskopf</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Sette</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Hensley</surname>
              <given-names>SE</given-names>
            </name>
            <name name-style="western">
              <surname>Davenport</surname>
              <given-names>MP</given-names>
            </name>
            <name name-style="western">
              <surname>Bates</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Luning Prak</surname>
              <given-names>ET</given-names>
            </name>
            <name name-style="western">
              <surname>Greenplate</surname>
              <given-names>AR</given-names>
            </name>
            <name name-style="western">
              <surname>Wherry</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern</article-title>
          <source>Science</source>
          <year>2021</year>
          <month>12</month>
          <day>03</day>
          <volume>374</volume>
          <issue>6572</issue>
          <fpage>abm0829</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.science.org/doi/abs/10.1126/science.abm0829?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub  0pubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1126/science.abm0829</pub-id>
          <pub-id pub-id-type="medline">34648302</pub-id>
          <pub-id pub-id-type="pmcid">PMC9284784</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Burki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>COVID vaccine booster doses for omicron variants</article-title>
          <source>Lancet Respir Med</source>
          <year>2022</year>
          <month>10</month>
          <volume>10</volume>
          <issue>10</issue>
          <fpage>936</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/36063833"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/S2213-2600(22)00361-7</pub-id>
          <pub-id pub-id-type="medline">36063833</pub-id>
          <pub-id pub-id-type="pii">S2213-2600(22)00361-7</pub-id>
          <pub-id pub-id-type="pmcid">PMC9439639</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Huangfu</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Mo</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Zeng</surname>
              <given-names>DD</given-names>
            </name>
            <name name-style="western">
              <surname>He</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine tweets after vaccine rollout: sentiment-based topic modeling</article-title>
          <source>J Med Internet Res</source>
          <year>2022</year>
          <month>02</month>
          <day>08</day>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>e31726</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2022/2/e31726/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/31726</pub-id>
          <pub-id pub-id-type="medline">34783665</pub-id>
          <pub-id pub-id-type="pii">v24i2e31726</pub-id>
          <pub-id pub-id-type="pmcid">PMC8827037</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Karami</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Zhu</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Goldschmidt</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Boyajieff</surname>
              <given-names>HR</given-names>
            </name>
            <name name-style="western">
              <surname>Najafabadi</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine and social media in the U.S.: exploring emotions and discussions on Twitter</article-title>
          <source>Vaccines (Basel)</source>
          <year>2021</year>
          <month>09</month>
          <day>23</day>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>1059</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=vaccines9101059"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/vaccines9101059</pub-id>
          <pub-id pub-id-type="medline">34696167</pub-id>
          <pub-id pub-id-type="pii">vaccines9101059</pub-id>
          <pub-id pub-id-type="pmcid">PMC8540945</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liew</surname>
              <given-names>TM</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Examining the utility of social media in COVID-19 vaccination: unsupervised learning of 672,133 Twitter posts</article-title>
          <source>JMIR Public Health Surveill</source>
          <year>2021</year>
          <month>11</month>
          <day>03</day>
          <volume>7</volume>
          <issue>11</issue>
          <fpage>e29789</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://publichealth.jmir.org/2021/11/e29789/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/29789</pub-id>
          <pub-id pub-id-type="medline">34583316</pub-id>
          <pub-id pub-id-type="pii">v7i11e29789</pub-id>
          <pub-id pub-id-type="pmcid">PMC8568045</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Monselise</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Chang</surname>
              <given-names>CH</given-names>
            </name>
            <name name-style="western">
              <surname>Ferreira</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Yang</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Topics and sentiments of public concerns regarding COVID-19 vaccines: social media trend analysis</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>10</month>
          <day>21</day>
          <volume>23</volume>
          <issue>10</issue>
          <fpage>e30765</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/10/e30765/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/30765</pub-id>
          <pub-id pub-id-type="medline">34581682</pub-id>
          <pub-id pub-id-type="pii">v23i10e30765</pub-id>
          <pub-id pub-id-type="pmcid">PMC8534488</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Shi</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Factors driving the popularity and virality of COVID-19 vaccine discourse on Twitter: text mining and data visualization study</article-title>
          <source>JMIR Public Health Surveill</source>
          <year>2021</year>
          <month>12</month>
          <day>03</day>
          <volume>7</volume>
          <issue>12</issue>
          <fpage>e32814</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://publichealth.jmir.org/2021/12/e32814/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/32814</pub-id>
          <pub-id pub-id-type="medline">34665761</pub-id>
          <pub-id pub-id-type="pii">v7i12e32814</pub-id>
          <pub-id pub-id-type="pmcid">PMC8647971</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sallam</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates</article-title>
          <source>Vaccines (Basel)</source>
          <year>2021</year>
          <month>02</month>
          <day>16</day>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>160</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=vaccines9020160"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/vaccines9020160</pub-id>
          <pub-id pub-id-type="medline">33669441</pub-id>
          <pub-id pub-id-type="pii">vaccines9020160</pub-id>
          <pub-id pub-id-type="pmcid">PMC7920465</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Melton</surname>
              <given-names>CA</given-names>
            </name>
            <name name-style="western">
              <surname>Olusanya</surname>
              <given-names>OA</given-names>
            </name>
            <name name-style="western">
              <surname>Ammar</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Shaban-Nejad</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Public sentiment analysis and topic modeling regarding COVID-19 vaccines on the Reddit social media platform: a call to action for strengthening vaccine confidence</article-title>
          <source>J Infect Public Health</source>
          <year>2021</year>
          <month>10</month>
          <volume>14</volume>
          <issue>10</issue>
          <fpage>1505</fpage>
          <lpage>12</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1876-0341(21)00228-8"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jiph.2021.08.010</pub-id>
          <pub-id pub-id-type="medline">34426095</pub-id>
          <pub-id pub-id-type="pii">S1876-0341(21)00228-8</pub-id>
          <pub-id pub-id-type="pmcid">PMC8364208</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hu</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Luo</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Huang</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Yan</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Ly</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Kacker</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>She</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Revealing public opinion towards COVID-19 vaccines with Twitter data in the United States: spatiotemporal perspective</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>09</month>
          <day>10</day>
          <volume>23</volume>
          <issue>9</issue>
          <fpage>e30854</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/9/e30854/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/30854</pub-id>
          <pub-id pub-id-type="medline">34346888</pub-id>
          <pub-id pub-id-type="pii">v23i9e30854</pub-id>
          <pub-id pub-id-type="pmcid">PMC8437406</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Guntuku</surname>
              <given-names>SC</given-names>
            </name>
            <name name-style="western">
              <surname>Buttenheim</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Sherman</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Merchant</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States</article-title>
          <source>Vaccine</source>
          <year>2021</year>
          <month>07</month>
          <day>05</day>
          <volume>39</volume>
          <issue>30</issue>
          <fpage>4034</fpage>
          <lpage>8</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34140171"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2021.06.014</pub-id>
          <pub-id pub-id-type="medline">34140171</pub-id>
          <pub-id pub-id-type="pii">S0264-410X(21)00738-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC8188387</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Chandrasekaran</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Desai</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Kumar</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Moustakas</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Examining public sentiments and attitudes toward COVID-19 vaccination: infoveillance study using Twitter posts</article-title>
          <source>JMIR Infodemiology</source>
          <year>2022</year>
          <month>04</month>
          <day>15</day>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>e33909</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/35462735"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/33909</pub-id>
          <pub-id pub-id-type="medline">35462735</pub-id>
          <pub-id pub-id-type="pii">v2i1e33909</pub-id>
          <pub-id pub-id-type="pmcid">PMC9014796</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Falsey</surname>
              <given-names>AR</given-names>
            </name>
            <name name-style="western">
              <surname>Sobieszczyk</surname>
              <given-names>ME</given-names>
            </name>
            <name name-style="western">
              <surname>Hirsch</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Sproule</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Robb</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Corey</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Neuzil</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Hahn</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Hunt</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mulligan</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>McEvoy</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>DeJesus</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Hassman</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Little</surname>
              <given-names>SJ</given-names>
            </name>
            <name name-style="western">
              <surname>Pahud</surname>
              <given-names>BA</given-names>
            </name>
            <name name-style="western">
              <surname>Durbin</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Pickrell</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Daar</surname>
              <given-names>ES</given-names>
            </name>
            <name name-style="western">
              <surname>Bush</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Solis</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Carr</surname>
              <given-names>QO</given-names>
            </name>
            <name name-style="western">
              <surname>Oyedele</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Buchbinder</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Cowden</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Vargas</surname>
              <given-names>SL</given-names>
            </name>
            <name name-style="western">
              <surname>Guerreros Benavides</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Call</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Keefer</surname>
              <given-names>MC</given-names>
            </name>
            <name name-style="western">
              <surname>Kirkpatrick</surname>
              <given-names>BD</given-names>
            </name>
            <name name-style="western">
              <surname>Pullman</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Tong</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Brewinski Isaacs</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Benkeser</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Janes</surname>
              <given-names>HE</given-names>
            </name>
            <name name-style="western">
              <surname>Nason</surname>
              <given-names>MC</given-names>
            </name>
            <name name-style="western">
              <surname>Green</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Kelly</surname>
              <given-names>EJ</given-names>
            </name>
            <name name-style="western">
              <surname>Maaske</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mueller</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Shoemaker</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Takas</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Marshall</surname>
              <given-names>RP</given-names>
            </name>
            <name name-style="western">
              <surname>Pangalos</surname>
              <given-names>MN</given-names>
            </name>
            <name name-style="western">
              <surname>Villafana</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Gonzalez-Lopez</surname>
              <given-names>A</given-names>
            </name>
            <collab>AstraZeneca AZD1222 Clinical Study Group</collab>
          </person-group>
          <article-title>Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine</article-title>
          <source>N Engl J Med</source>
          <year>2021</year>
          <month>12</month>
          <day>16</day>
          <volume>385</volume>
          <issue>25</issue>
          <fpage>2348</fpage>
          <lpage>60</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34587382"/>
          </comment>
          <pub-id pub-id-type="doi">10.1056/NEJMoa2105290</pub-id>
          <pub-id pub-id-type="medline">34587382</pub-id>
          <pub-id pub-id-type="pmcid">PMC8522798</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Polack</surname>
              <given-names>FP</given-names>
            </name>
            <name name-style="western">
              <surname>Thomas</surname>
              <given-names>SJ</given-names>
            </name>
            <name name-style="western">
              <surname>Kitchin</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Absalon</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Gurtman</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Lockhart</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Perez</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Pérez Marc</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Moreira</surname>
              <given-names>ED</given-names>
            </name>
            <name name-style="western">
              <surname>Zerbini</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bailey</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Swanson</surname>
              <given-names>KA</given-names>
            </name>
            <name name-style="western">
              <surname>Roychoudhury</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Koury</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Kalina</surname>
              <given-names>WV</given-names>
            </name>
            <name name-style="western">
              <surname>Cooper</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Frenck Jr</surname>
              <given-names>RW</given-names>
            </name>
            <name name-style="western">
              <surname>Hammitt</surname>
              <given-names>LL</given-names>
            </name>
            <name name-style="western">
              <surname>Türeci</surname>
              <given-names>Ö</given-names>
            </name>
            <name name-style="western">
              <surname>Nell</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Schaefer</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Ünal</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Tresnan</surname>
              <given-names>DB</given-names>
            </name>
            <name name-style="western">
              <surname>Mather</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Dormitzer</surname>
              <given-names>PR</given-names>
            </name>
            <name name-style="western">
              <surname>Şahin</surname>
              <given-names>U</given-names>
            </name>
            <name name-style="western">
              <surname>Jansen</surname>
              <given-names>KU</given-names>
            </name>
            <name name-style="western">
              <surname>Gruber</surname>
              <given-names>WC</given-names>
            </name>
            <collab>C4591001 Clinical Trial Group</collab>
          </person-group>
          <article-title>Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine</article-title>
          <source>N Engl J Med</source>
          <year>2020</year>
          <month>12</month>
          <day>31</day>
          <volume>383</volume>
          <issue>27</issue>
          <fpage>2603</fpage>
          <lpage>15</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/33301246"/>
          </comment>
          <pub-id pub-id-type="doi">10.1056/NEJMoa2034577</pub-id>
          <pub-id pub-id-type="medline">33301246</pub-id>
          <pub-id pub-id-type="pmcid">PMC7745181</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <nlm-citation citation-type="web">
          <article-title>Vaccination data</article-title>
          <source>World Health Organization</source>
          <year>2022</year>
          <access-date>2022-06-15</access-date>
          <publisher-loc>Geneva, Switzerland</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://covid19.who.int/data">https://covid19.who.int/data</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Boucher</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Cornelson</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Benham</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Fullerton</surname>
              <given-names>MM</given-names>
            </name>
            <name name-style="western">
              <surname>Tang</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Constantinescu</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Mourali</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Oxoby</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Marshall</surname>
              <given-names>DA</given-names>
            </name>
            <name name-style="western">
              <surname>Hemmati</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Badami</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Hu</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Lang</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Analyzing social media to explore the attitudes and behaviors following the announcement of successful COVID-19 vaccine trials: infodemiology study</article-title>
          <source>JMIR Infodemiology</source>
          <year>2021</year>
          <month>08</month>
          <day>12</day>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>e28800</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34447924"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/28800</pub-id>
          <pub-id pub-id-type="medline">34447924</pub-id>
          <pub-id pub-id-type="pii">v1i1e28800</pub-id>
          <pub-id pub-id-type="pmcid">PMC8363124</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jiang</surname>
              <given-names>LC</given-names>
            </name>
            <name name-style="western">
              <surname>Chu</surname>
              <given-names>TH</given-names>
            </name>
            <name name-style="western">
              <surname>Sun</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Characterization of vaccine tweets during the early stage of the COVID-19 outbreak in the United States: topic modeling analysis</article-title>
          <source>JMIR Infodemiology</source>
          <year>2021</year>
          <month>09</month>
          <day>14</day>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>e25636</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34604707"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/25636</pub-id>
          <pub-id pub-id-type="medline">34604707</pub-id>
          <pub-id pub-id-type="pii">v1i1e25636</pub-id>
          <pub-id pub-id-type="pmcid">PMC8448459</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shim</surname>
              <given-names>JG</given-names>
            </name>
            <name name-style="western">
              <surname>Ryu</surname>
              <given-names>KH</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
            <name name-style="western">
              <surname>Cho</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>YJ</given-names>
            </name>
            <name name-style="western">
              <surname>Ahn</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Text mining approaches to analyze public sentiment changes regarding COVID-19 vaccines on social media in Korea</article-title>
          <source>Int J Environ Res Public Health</source>
          <year>2021</year>
          <month>06</month>
          <day>18</day>
          <volume>18</volume>
          <issue>12</issue>
          <fpage>6549</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=ijerph18126549"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/ijerph18126549</pub-id>
          <pub-id pub-id-type="medline">34207016</pub-id>
          <pub-id pub-id-type="pii">ijerph18126549</pub-id>
          <pub-id pub-id-type="pmcid">PMC8296514</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Luo</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Cui</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Liao</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Exploring public perceptions of the COVID-19 vaccine online from a cultural perspective: semantic network analysis of two social media platforms in the United States and China</article-title>
          <source>Telemat Inform</source>
          <year>2021</year>
          <month>12</month>
          <volume>65</volume>
          <fpage>101712</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/34887618"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.tele.2021.101712</pub-id>
          <pub-id pub-id-type="medline">34887618</pub-id>
          <pub-id pub-id-type="pii">S0736-5853(21)00151-9</pub-id>
          <pub-id pub-id-type="pmcid">PMC8429027</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jiang</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Su</surname>
              <given-names>MH</given-names>
            </name>
            <name name-style="western">
              <surname>Hwang</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Lian</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Brauer</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Polarization over vaccination: ideological differences in Twitter expression about COVID-19 vaccine favorability and specific hesitancy concerns</article-title>
          <source>Soc Media Soc</source>
          <year>2021</year>
          <month>09</month>
          <day>30</day>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>205630512110484</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/full/10.1177/20563051211048413"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/20563051211048413</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ghosh</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A comparative study on distancing, mask and vaccine adoption rates from global Twitter trends</article-title>
          <source>Healthcare (Basel)</source>
          <year>2021</year>
          <month>04</month>
          <day>21</day>
          <volume>9</volume>
          <issue>5</issue>
          <fpage>488</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=healthcare9050488"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/healthcare9050488</pub-id>
          <pub-id pub-id-type="medline">33919097</pub-id>
          <pub-id pub-id-type="pii">healthcare9050488</pub-id>
          <pub-id pub-id-type="pmcid">PMC8143090</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kwok</surname>
              <given-names>SW</given-names>
            </name>
            <name name-style="western">
              <surname>Vadde</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Tweet topics and sentiments relating to COVID-19 vaccination among Australian Twitter Users: machine learning analysis</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>05</month>
          <day>19</day>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>e26953</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/5/e26953/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/26953</pub-id>
          <pub-id pub-id-type="medline">33886492</pub-id>
          <pub-id pub-id-type="pii">v23i5e26953</pub-id>
          <pub-id pub-id-type="pmcid">PMC8136408</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Yan</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Law</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Nguyen</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Cheung</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Kong</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Comparing public sentiment toward COVID-19 vaccines across Canadian cities: analysis of comments on Reddit</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>09</month>
          <day>24</day>
          <volume>23</volume>
          <issue>9</issue>
          <fpage>e32685</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/9/e32685/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/32685</pub-id>
          <pub-id pub-id-type="medline">34519654</pub-id>
          <pub-id pub-id-type="pii">v23i9e32685</pub-id>
          <pub-id pub-id-type="pmcid">PMC8477909</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lyu</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Han</surname>
              <given-names>EL</given-names>
            </name>
            <name name-style="western">
              <surname>Luli</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine-related discussion on Twitter: topic modeling and sentiment analysis</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>06</month>
          <day>29</day>
          <volume>23</volume>
          <issue>6</issue>
          <fpage>e24435</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/6/e24435/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/24435</pub-id>
          <pub-id pub-id-type="medline">34115608</pub-id>
          <pub-id pub-id-type="pii">v23i6e24435</pub-id>
          <pub-id pub-id-type="pmcid">PMC8244724</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Public attitudes toward COVID-19 vaccines on English-language Twitter: a sentiment analysis</article-title>
          <source>Vaccine</source>
          <year>2021</year>
          <month>09</month>
          <day>15</day>
          <volume>39</volume>
          <issue>39</issue>
          <fpage>5499</fpage>
          <lpage>505</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34452774"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2021.08.058</pub-id>
          <pub-id pub-id-type="medline">34452774</pub-id>
          <pub-id pub-id-type="pii">S0264-410X(21)01106-3</pub-id>
          <pub-id pub-id-type="pmcid">PMC8439574</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hussain</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Tahir</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Hussain</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Sheikh</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Gogate</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Dashtipour</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Ali</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Sheikh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Artificial intelligence-enabled analysis of public attitudes on Facebook and Twitter toward COVID-19 vaccines in the United Kingdom and the United States: observational study</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>04</month>
          <day>05</day>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>e26627</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/4/e26627/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/26627</pub-id>
          <pub-id pub-id-type="medline">33724919</pub-id>
          <pub-id pub-id-type="pii">v23i4e26627</pub-id>
          <pub-id pub-id-type="pmcid">PMC8023383</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cotfas</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Delcea</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Roxin</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Ioanas</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Gherai</surname>
              <given-names>DS</given-names>
            </name>
            <name name-style="western">
              <surname>Tajariol</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The longest month: analyzing COVID-19 vaccination opinions dynamics from Tweets in the month following the first vaccine announcement</article-title>
          <source>IEEE Access</source>
          <year>2021</year>
          <month>02</month>
          <day>16</day>
          <volume>9</volume>
          <fpage>33203</fpage>
          <lpage>23</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34786309"/>
          </comment>
          <pub-id pub-id-type="doi">10.1109/ACCESS.2021.3059821</pub-id>
          <pub-id pub-id-type="medline">34786309</pub-id>
          <pub-id pub-id-type="pmcid">PMC8545223</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Leveraging transfer learning to analyze opinions, attitudes, and behavioral intentions toward COVID-19 vaccines: social media content and temporal analysis</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>08</month>
          <day>10</day>
          <volume>23</volume>
          <issue>8</issue>
          <fpage>e30251</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/8/e30251/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/30251</pub-id>
          <pub-id pub-id-type="medline">34254942</pub-id>
          <pub-id pub-id-type="pii">v23i8e30251</pub-id>
          <pub-id pub-id-type="pmcid">PMC8360338</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Marcec</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Likic</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines</article-title>
          <source>Postgrad Med J</source>
          <year>2022</year>
          <month>07</month>
          <volume>98</volume>
          <issue>1161</issue>
          <fpage>544</fpage>
          <lpage>50</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34373343"/>
          </comment>
          <pub-id pub-id-type="doi">10.1136/postgradmedj-2021-140685</pub-id>
          <pub-id pub-id-type="medline">34373343</pub-id>
          <pub-id pub-id-type="pii">postgradmedj-2021-140685</pub-id>
          <pub-id pub-id-type="pmcid">PMC8354810</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <nlm-citation citation-type="web">
          <article-title>Academic Research access</article-title>
          <source>Twitter Developer Platform</source>
          <year>2022</year>
          <access-date>2022-10-28</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://developer.twitter.com/en/products/twitter-api/academic-research">https://developer.twitter.com/en/products/twitter-api/academic-research</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mimno</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Wallach</surname>
              <given-names>HM</given-names>
            </name>
            <name name-style="western">
              <surname>Talley</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Leenders</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>McCallum</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Optimizing semantic coherence in topic models</article-title>
          <source>Proceedings of the 2011 Conference on Empirical Methods in Natural Language Processing</source>
          <year>2011</year>
          <conf-name>EMNLP '11</conf-name>
          <conf-date>July 27-31, 2011</conf-date>
          <conf-loc>Edinburgh, UK</conf-loc>
          <fpage>262</fpage>
          <lpage>72</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://dl.acm.org/doi/10.5555/2145432.2145462"/>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Zhao</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Perkins</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Ge</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Ding</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Zou</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>A heuristic approach to determine an appropriate number of topics in topic modeling</article-title>
          <source>BMC Bioinformatics</source>
          <year>2015</year>
          <volume>16</volume>
          <issue>Suppl 13</issue>
          <fpage>S8</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-16-S13-S8"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/1471-2105-16-S13-S8</pub-id>
          <pub-id pub-id-type="medline">26424364</pub-id>
          <pub-id pub-id-type="pii">1471-2105-16-S13-S8</pub-id>
          <pub-id pub-id-type="pmcid">PMC4597325</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <nlm-citation citation-type="confproc">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Arun</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Suresh</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Veni Madhavan</surname>
              <given-names>CE</given-names>
            </name>
            <name name-style="western">
              <surname>Narasimha Murthy</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>On finding the natural number of topics with latent Dirichlet allocation: some observations</article-title>
          <source>Proceedings of the 14th Pacific-Asia Conference on Advances in Knowledge Discovery and Data Mining</source>
          <year>2010</year>
          <conf-name>PAKDD '10</conf-name>
          <conf-date>June 21-24, 2010</conf-date>
          <conf-loc>Hyderabad, India</conf-loc>
          <fpage>391</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="doi">10.1007/978-3-642-13657-3_43</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Xia</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Tang</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A density-based method for adaptive LDA model selection</article-title>
          <source>Neurocomputing</source>
          <year>2009</year>
          <month>3</month>
          <volume>72</volume>
          <issue>7-9</issue>
          <fpage>1775</fpage>
          <lpage>81</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://doi.org/10.1016/j.neucom.2008.06.011"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.neucom.2008.06.011</pub-id>
          <pub-id pub-id-type="pii">S0302-2838(22)02873-1</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Deveaud</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>SanJuan</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Bellot</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Accurate and effective latent concept modeling for ad hoc information retrieval</article-title>
          <source>Doc Numer</source>
          <year>2014</year>
          <month>04</month>
          <day>30</day>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>84</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cairn.info/revue-document-numerique-2014-1-page-61.htm"/>
          </comment>
          <pub-id pub-id-type="doi">10.3166/dn.17.1.61-84</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Griffiths</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>Steyvers</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Finding scientific topics</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <month>04</month>
          <day>06</day>
          <volume>101</volume>
          <issue>Suppl 1</issue>
          <fpage>5228</fpage>
          <lpage>35</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/14872004"/>
          </comment>
          <pub-id pub-id-type="doi">10.1073/pnas.0307752101</pub-id>
          <pub-id pub-id-type="medline">14872004</pub-id>
          <pub-id pub-id-type="pii">0307752101</pub-id>
          <pub-id pub-id-type="pmcid">PMC387300</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ying</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Montgomery</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Stewart</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Topics, concepts, and measurement: a crowdsourced procedure for validating topics as measures</article-title>
          <source>Polit Anal</source>
          <year>2021</year>
          <month>09</month>
          <day>27</day>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>570</fpage>
          <lpage>89</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cambridge.org/core/journals/political-analysis/article/abs/topics-concepts-and-measurement-a-crowdsourced-procedure-for-validating-topics-as-measures/F28DC93AFD4C8DE63CC235BC6D684257"/>
          </comment>
          <pub-id pub-id-type="doi">10.1017/pan.2021.33</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <nlm-citation citation-type="web">
          <article-title>SentiStrength</article-title>
          <source>The CyberEmotions Project</source>
          <access-date>2022-10-28</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://sentistrength.wlv.ac.uk/">http://sentistrength.wlv.ac.uk/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <nlm-citation citation-type="web">
          <article-title>KNU Korean Sentiment Dictionary</article-title>
          <source>Kunsan National University</source>
          <access-date>2022-10-28</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://dilab.kunsan.ac.kr/knu/knu.html">http://dilab.kunsan.ac.kr/knu/knu.html</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Chow</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Tests of equality between sets of coefficients in two linear regressions</article-title>
          <source>Econometrica</source>
          <year>1960</year>
          <month>07</month>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>591</fpage>
          <lpage>605</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jstor.org/stable/1910133"/>
          </comment>
          <pub-id pub-id-type="doi">10.2307/1910133</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sun</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Luo</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A review of natural language processing techniques for opinion mining systems</article-title>
          <source>Inf Fusion</source>
          <year>2017</year>
          <month>07</month>
          <volume>36</volume>
          <fpage>10</fpage>
          <lpage>25</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://doi.org/10.1016/j.inffus.2016.10.004"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jclinane.2016.09.027</pub-id>
          <pub-id pub-id-type="pii">S0952-8180(16)30519-0</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref43">
        <label>43</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Murphy</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Link</surname>
              <given-names>MW</given-names>
            </name>
            <name name-style="western">
              <surname>Childs</surname>
              <given-names>JH</given-names>
            </name>
            <name name-style="western">
              <surname>Tesfaye</surname>
              <given-names>CL</given-names>
            </name>
            <name name-style="western">
              <surname>Dean</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Stern</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Pasek</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Callegaro</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Harwood</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Social media in public opinion research: report of the AAPOR task force on emerging technologies in public opinion research</article-title>
          <source>American Association for Public Opinion Research</source>
          <year>2014</year>
          <month>5</month>
          <day>28</day>
          <access-date>2022-10-28</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www-archive.aapor.org/Education-Resources/Reports/Social-Media-in-Public-Opinion-Research.aspx">https://www-archive.aapor.org/Education-Resources/Reports/Social-Media-in-Public-​Opinion-Research.aspx</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref44">
        <label>44</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mavragani</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Infodemiology and infoveillance: scoping review</article-title>
          <source>J Med Internet Res</source>
          <year>2020</year>
          <month>04</month>
          <day>28</day>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>e16206</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2020/4/e16206/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/16206</pub-id>
          <pub-id pub-id-type="medline">32310818</pub-id>
          <pub-id pub-id-type="pii">v22i4e16206</pub-id>
          <pub-id pub-id-type="pmcid">PMC7189791</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref45">
        <label>45</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bour</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Ahne</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Schmitz</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Perchoux</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Dessenne</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Fagherazzi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The use of social media for health research purposes: scoping review</article-title>
          <source>J Med Internet Res</source>
          <year>2021</year>
          <month>05</month>
          <day>27</day>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>e25736</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2021/5/e25736/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/25736</pub-id>
          <pub-id pub-id-type="medline">34042593</pub-id>
          <pub-id pub-id-type="pii">v23i5e25736</pub-id>
          <pub-id pub-id-type="pmcid">PMC8193478</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref46">
        <label>46</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Baden</surname>
              <given-names>LR</given-names>
            </name>
            <name name-style="western">
              <surname>El Sahly</surname>
              <given-names>HM</given-names>
            </name>
            <name name-style="western">
              <surname>Essink</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Kotloff</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Frey</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Novak</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Diemert</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Spector</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Rouphael</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Creech</surname>
              <given-names>CB</given-names>
            </name>
            <name name-style="western">
              <surname>McGettigan</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Khetan</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Segall</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Solis</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Brosz</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Fierro</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Schwartz</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Neuzil</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Corey</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Gilbert</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Janes</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Follmann</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Marovich</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Mascola</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Polakowski</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Ledgerwood</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Graham</surname>
              <given-names>BS</given-names>
            </name>
            <name name-style="western">
              <surname>Bennett</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Pajon</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Knightly</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Leav</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Deng</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Zhou</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Han</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ivarsson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Miller</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Zaks</surname>
              <given-names>T</given-names>
            </name>
            <collab>COVE Study Group</collab>
          </person-group>
          <article-title>Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine</article-title>
          <source>N Engl J Med</source>
          <year>2021</year>
          <month>02</month>
          <day>04</day>
          <volume>384</volume>
          <issue>5</issue>
          <fpage>403</fpage>
          <lpage>16</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/33378609"/>
          </comment>
          <pub-id pub-id-type="doi">10.1056/NEJMoa2035389</pub-id>
          <pub-id pub-id-type="medline">33378609</pub-id>
          <pub-id pub-id-type="pmcid">PMC7787219</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref47">
        <label>47</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sadoff</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Gray</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Vandebosch</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Cárdenas</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Shukarev</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Grinsztejn</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Goepfert</surname>
              <given-names>PA</given-names>
            </name>
            <name name-style="western">
              <surname>Truyers</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Fennema</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Spiessens</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Offergeld</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Scheper</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>KL</given-names>
            </name>
            <name name-style="western">
              <surname>Robb</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Treanor</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Barouch</surname>
              <given-names>DH</given-names>
            </name>
            <name name-style="western">
              <surname>Stoddard</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ryser</surname>
              <given-names>MF</given-names>
            </name>
            <name name-style="western">
              <surname>Marovich</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Neuzil</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Corey</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Cauwenberghs</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Tanner</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Hardt</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Ruiz-Guiñazú</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Le Gars</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Schuitemaker</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Van Hoof</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Struyf</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Douoguih</surname>
              <given-names>M</given-names>
            </name>
            <collab>ENSEMBLE Study Group</collab>
          </person-group>
          <article-title>Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19</article-title>
          <source>N Engl J Med</source>
          <year>2021</year>
          <month>06</month>
          <day>10</day>
          <volume>384</volume>
          <issue>23</issue>
          <fpage>2187</fpage>
          <lpage>201</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/33882225"/>
          </comment>
          <pub-id pub-id-type="doi">10.1056/NEJMoa2101544</pub-id>
          <pub-id pub-id-type="medline">33882225</pub-id>
          <pub-id pub-id-type="pmcid">PMC8220996</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref48">
        <label>48</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hajduczok</surname>
              <given-names>AG</given-names>
            </name>
            <name name-style="western">
              <surname>DiJoseph</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Bent</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Thorp</surname>
              <given-names>AK</given-names>
            </name>
            <name name-style="western">
              <surname>Mullholand</surname>
              <given-names>JB</given-names>
            </name>
            <name name-style="western">
              <surname>MacKay</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Barik</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Coleman</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Paules</surname>
              <given-names>CI</given-names>
            </name>
            <name name-style="western">
              <surname>Tinsley</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Physiologic response to the Pfizer-BioNTech COVID-19 vaccine measured using wearable devices: prospective observational study</article-title>
          <source>JMIR Form Res</source>
          <year>2021</year>
          <month>08</month>
          <day>04</day>
          <volume>5</volume>
          <issue>8</issue>
          <fpage>e28568</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://formative.jmir.org/2021/8/e28568/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/28568</pub-id>
          <pub-id pub-id-type="medline">34236995</pub-id>
          <pub-id pub-id-type="pii">v5i8e28568</pub-id>
          <pub-id pub-id-type="pmcid">PMC8341091</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref49">
        <label>49</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Male</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Menstrual changes after covid-19 vaccination</article-title>
          <source>BMJ</source>
          <year>2021</year>
          <month>09</month>
          <day>15</day>
          <volume>374</volume>
          <fpage>n2211</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34526310/"/>
          </comment>
          <pub-id pub-id-type="doi">10.1136/bmj.n2211</pub-id>
          <pub-id pub-id-type="medline">34526310</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref50">
        <label>50</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Male</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Menstruation and COVID-19 vaccination</article-title>
          <source>BMJ</source>
          <year>2022</year>
          <month>01</month>
          <day>26</day>
          <volume>376</volume>
          <fpage>o142</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35082132/"/>
          </comment>
          <pub-id pub-id-type="doi">10.1136/bmj.o142</pub-id>
          <pub-id pub-id-type="medline">35082132</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref51">
        <label>51</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sherman</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Sim</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Cutts</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Dasch</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Amlôt</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Rubin</surname>
              <given-names>GJ</given-names>
            </name>
            <name name-style="western">
              <surname>Sevdalis</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccination acceptability in the UK at the start of the vaccination programme: a nationally representative cross-sectional survey (CoVAccS - wave 2)</article-title>
          <source>Public Health</source>
          <year>2022</year>
          <month>01</month>
          <volume>202</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34856520"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.puhe.2021.10.008</pub-id>
          <pub-id pub-id-type="medline">34856520</pub-id>
          <pub-id pub-id-type="pii">S0033-3506(21)00414-5</pub-id>
          <pub-id pub-id-type="pmcid">PMC8520876</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref52">
        <label>52</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hotez</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Batista</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Ergonul</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Figueroa</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Gilbert</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Gursel</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Hassanain</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Kang</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name name-style="western">
              <surname>Lall</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Larson</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Naniche</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Sheahan</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Shoham</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Wilder-Smith</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Strub-Wourgaft</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Yadav</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Bottazzi</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and therapeutics task force members</article-title>
          <source>EClinicalMedicine</source>
          <year>2021</year>
          <month>03</month>
          <volume>33</volume>
          <fpage>100780</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S2589-5370(21)00060-2"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.eclinm.2021.100780</pub-id>
          <pub-id pub-id-type="medline">33718854</pub-id>
          <pub-id pub-id-type="pii">S2589-5370(21)00060-2</pub-id>
          <pub-id pub-id-type="pmcid">PMC7935671</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref53">
        <label>53</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>You</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Direct and indirect associations of media use with COVID-19 vaccine hesitancy in South Korea: cross-sectional web-based survey</article-title>
          <source>J Med Internet Res</source>
          <year>2022</year>
          <month>01</month>
          <day>06</day>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>e32329</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.jmir.org/2022/1/e32329/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/32329</pub-id>
          <pub-id pub-id-type="medline">34870605</pub-id>
          <pub-id pub-id-type="pii">v24i1e32329</pub-id>
          <pub-id pub-id-type="pmcid">PMC8734608</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref54">
        <label>54</label>
        <nlm-citation citation-type="web">
          <article-title>Factbox: countries making COVID-19 vaccines mandatory</article-title>
          <source>Reuters</source>
          <year>2021</year>
          <month>12</month>
          <day>31</day>
          <access-date>2022-06-30</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.reuters.com/business/healthcare-pharmaceuticals/countries-making-covid-19-vaccines-mandatory-2021-08-16/">https://www.reuters.com/business/healthcare-pharmaceuticals/countries-making-covid-19-vaccines-mandatory-2021-08-16/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref55">
        <label>55</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gagneux-Brunon</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Botelho-Nevers</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Bonneton</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Peretti-Watel</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Verger</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Launay</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Ward</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2022</year>
          <month>03</month>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>433</fpage>
          <lpage>9</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34774756"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.cmi.2021.10.016</pub-id>
          <pub-id pub-id-type="medline">34774756</pub-id>
          <pub-id pub-id-type="pii">S1198-743X(21)00617-0</pub-id>
          <pub-id pub-id-type="pmcid">PMC8912915</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref56">
        <label>56</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Albalawi</surname>
              <given-names>OM</given-names>
            </name>
            <name name-style="western">
              <surname>Alomran</surname>
              <given-names>MI</given-names>
            </name>
            <name name-style="western">
              <surname>Alsagri</surname>
              <given-names>GM</given-names>
            </name>
            <name name-style="western">
              <surname>Althunian</surname>
              <given-names>TA</given-names>
            </name>
            <name name-style="western">
              <surname>Alshammari</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Analyzing the U.S. post-marketing safety surveillance of COVID-19 vaccines</article-title>
          <source>Saudi Pharm J</source>
          <year>2022</year>
          <month>02</month>
          <volume>30</volume>
          <issue>2</issue>
          <fpage>180</fpage>
          <lpage>4</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1319-0164(21)00257-7"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jsps.2021.12.008</pub-id>
          <pub-id pub-id-type="medline">35002372</pub-id>
          <pub-id pub-id-type="pii">S1319-0164(21)00257-7</pub-id>
          <pub-id pub-id-type="pmcid">PMC8719360</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref57">
        <label>57</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rashedi</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Samieefar</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Masoumi</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Mohseni</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Rezaei</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccines mix-and-match: the concept, the efficacy and the doubts</article-title>
          <source>J Med Virol</source>
          <year>2022</year>
          <month>04</month>
          <volume>94</volume>
          <issue>4</issue>
          <fpage>1294</fpage>
          <lpage>9</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/34796525"/>
          </comment>
          <pub-id pub-id-type="doi">10.1002/jmv.27463</pub-id>
          <pub-id pub-id-type="medline">34796525</pub-id>
          <pub-id pub-id-type="pmcid">PMC8661746</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref58">
        <label>58</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Huang</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Hu</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Hohl</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>She</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Gong</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Gruebner</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name name-style="western">
              <surname>Ye</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Social media mining under the COVID-19 context: progress, challenges, and opportunities</article-title>
          <source>Int J Appl Earth Obs Geoinf</source>
          <year>2022</year>
          <month>09</month>
          <volume>113</volume>
          <fpage>102967</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://europepmc.org/abstract/MED/36035895"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jag.2022.102967</pub-id>
          <pub-id pub-id-type="medline">36035895</pub-id>
          <pub-id pub-id-type="pii">S1569-8432(22)00160-1</pub-id>
          <pub-id pub-id-type="pmcid">PMC9391053</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
